Effect of heparin and sulfated polysaccharides on in vitro hepatic phagocytosis.
D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology; D002807:Chondroitin / Q000494:pharmacology*; D003911:Dextrans / Q000494:pharmacology*; D006025:Glycosaminoglycans / Q000494:pharmacology*; D006048:Gold Colloid, Radioactive / Q000097:blood / Q000378:metabolism; D006493:Heparin / Q000494:pharmacology*; D066298:In Vitro Techniques; D008099:Liver / Q000166:cytology* / Q000187:drug effects; D008297:Male; D012157:Mononuclear Phagocyte System / Q000166:cytology* / Q000187:drug effects; D010070:Oxalates; D010587:Phagocytosis / Q000187:drug effects*; D051381:Rats; D012711:Serum Albumin, Radio-Iodinated / Q000378:metabolism; D015054:Zymosan / Q000494:pharmacology*
D000925:Anticoagulants; D003911:Dextrans; D006025:Glycosaminoglycans; D006048:Gold Colloid, Radioactive; D010070:Oxalates; D012711:Serum Albumin, Radio-Iodinated; D006493:Heparin; D002807:Chondroitin; D015054:Zymosan